Item does not contain fulltextA better diabetes regulation seems possible, with the aid of the recently available insulin analogs than with isophane insulin, for patients with diabetes mellitus type 1 or 2. The glycaemic regulation can be improved and/or the chances of hypoglycaemia can be reduced by reduced variability in the resorption of (insulin glargine) or by binding to the serum albumin (insulin detemir). With poor regulation it seems possible to bring about a substantial HbA1c reduction without an increase in hypoglycaemic incidents, and with reasonable to good regulation to achieve a reduction of the number of hypoglycaemias whilst HbA1c remains the same
Insulin analogues, developed by molecular engineering, have structural changes in the A and B insul...
Insulin detemir is a soluble long-acting human insulin analogue at neutral pH with a unique mechanis...
Hypoglycemia is recognized as the principal limitation to intensive insulin therapy and is associate...
A better diabetes regulation seems possible, with the aid of the recently available insulin analogs ...
Insulin therapy in diabetes, both at on-set and after several years ’ duration, isprimarily directed...
The treatment of type 1 diabetes mellitus consists of external replacement of the functions of β cel...
Current insulin treatment regimens effectivelycombat post-prandial hyperglycaemia, but areunable to ...
CONTEXT: Among the growing population of individuals with type 2 diabetes mellitus, many patients ar...
Contains fulltext : 172828.pdf (publisher's version ) (Open Access)There is ongoin...
Diabetes is a metabolic disease with high prevalence worldwide. Exogenous insulin is used in the ma...
Diabetes is a metabolic disease with high prevalence worldwide. Exogenous insulin is used in the ma...
Achieving optimal blood glucose control in Type 1 diabetes is a delicate balance between ensuring ti...
Achieving optimal blood glucose control in Type 1 diabetes is a delicate balance between ensuring ti...
While the existing insulin analogues have certain advantages and are capable of achieving glycemic c...
Tight glycaemic control is essential to reduce therisk of developing the micro- and macrovascularcom...
Insulin analogues, developed by molecular engineering, have structural changes in the A and B insul...
Insulin detemir is a soluble long-acting human insulin analogue at neutral pH with a unique mechanis...
Hypoglycemia is recognized as the principal limitation to intensive insulin therapy and is associate...
A better diabetes regulation seems possible, with the aid of the recently available insulin analogs ...
Insulin therapy in diabetes, both at on-set and after several years ’ duration, isprimarily directed...
The treatment of type 1 diabetes mellitus consists of external replacement of the functions of β cel...
Current insulin treatment regimens effectivelycombat post-prandial hyperglycaemia, but areunable to ...
CONTEXT: Among the growing population of individuals with type 2 diabetes mellitus, many patients ar...
Contains fulltext : 172828.pdf (publisher's version ) (Open Access)There is ongoin...
Diabetes is a metabolic disease with high prevalence worldwide. Exogenous insulin is used in the ma...
Diabetes is a metabolic disease with high prevalence worldwide. Exogenous insulin is used in the ma...
Achieving optimal blood glucose control in Type 1 diabetes is a delicate balance between ensuring ti...
Achieving optimal blood glucose control in Type 1 diabetes is a delicate balance between ensuring ti...
While the existing insulin analogues have certain advantages and are capable of achieving glycemic c...
Tight glycaemic control is essential to reduce therisk of developing the micro- and macrovascularcom...
Insulin analogues, developed by molecular engineering, have structural changes in the A and B insul...
Insulin detemir is a soluble long-acting human insulin analogue at neutral pH with a unique mechanis...
Hypoglycemia is recognized as the principal limitation to intensive insulin therapy and is associate...